meta_pixel
Tapesearch Logo
Log in
Science Talk

Advancing Efforts in Disease Interception

Science Talk

Scientific American

Science

4.2644 Ratings

🗓️ 27 February 2020

⏱️ 22 minutes

🧾️ Download transcript

Summary

Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

There are some things you should always check, like the hygiene rating on your local takeaway,

0:06.2

the setting on your razor, and whether the party actually is fancy dress.

0:11.1

The other thing you should check is your Experian credit report, especially if you're looking to borrow money.

0:17.2

It lets you understand what lenders see, so you can increase your chances of getting the best deals.

0:22.8

It's dead easy to check it and completely free.

0:26.6

See it in seconds. Download the Experian app today.

0:30.9

Welcome to Scientific American Science Talk posted on February 27th, 2020.

0:36.5

I'm Steve Merski. On this episode, there appears to be what we

0:40.6

call a missing microbiome. And in those individuals with the missing microbiome, they appear to be

0:46.4

much higher at risk for these autoimmune and these other immune diseases that present early in life.

0:52.1

That's Ben Wiegand. He received a doctorate in physical chemistry from Harvard.

0:56.7

You may have seen bumper stickers that say honk if you pass P-Chem.

1:00.3

Weigand is now the global head of the World Without Disease Accelerator, the WWDA, at Jansen,

1:07.3

the pharmaceutical companies of Johnson and Johnson, where he's involved in multiple efforts

1:11.8

to prevent disease or identify it in its earliest stages for more effective treatments.

1:17.2

We spoke by phone.

1:19.5

What is the WWDA?

1:21.8

So the WWDA, or we would call the World Without Disease Accelerator, our focus is trying to positively affect the future of

1:30.5

health care. We realize that today, as people get older, they're living longer, but unfortunately,

1:37.8

almost half of people that are 40 years or older have multiple comorbidities, and by 65, 95% of Americans will have two or more

1:47.9

comorbidities. So while they're living longer lives, we have what I call passengers along

1:53.8

the ride with us, whether it's diabetes or Alzheimer's or hypertension. And so our idea and our vision is that we would, you know, if we had

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Scientific American, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Scientific American and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.